Navigation Links
Phlo Affiliate Reports AQUISS to be Sold in 450 7-Eleven Stores
Date:9/27/2007

Launch Set for October

JACKSONVILLE, Fla., Sept. 27 /PRNewswire-FirstCall/ -- An affiliate of Phlo Corporation (OTC: PHLC) (the "Company") announced today that its performance/vitality beverage product, AQUISS(TM), will be sold in 450 7-Eleven stores from Bakersfield, California to the Oregon border. 7-Eleven plans a launch of AQUISS(TM) in October. The roll-out will include an aggressive sampling campaign to acquaint 7-Eleven's customers with the technology and unique assets of AQUISS(TM).

"We are all very excited about this major 7-Eleven development so early in the distribution process, as its puts AQUISS(TM) on the map," James B. Hovis, CEO of the Company said today. "This should have a major impact on the revenue of the Company shortly and over the long term."

Recently, AQUISS(TM) was purchased by Palo Alto Egg Co. Palo Alto Egg Co. is a customer of Bon Appetit, which services the food and beverage requirements of such Silicon Valley companies as Google, Yahoo, and Intel. Other new accounts of note which have recently purchased AQUISS(TM) include Eagle Ridge Golf Course, Cazadores Bottle Shop, Neighborhood Gas Mart, Coach House, Chualar Market, Deluxe Foods, Easy Mart, Key Market, Lulu's Fiesta Liquors, Fish Lady, Valley Liquors, Oak Park Market, and Bozzo's Liquors.

AQUISS(TM) was presented at a significant trade show held at the Fairmont Hotel in San Jose. The trade show was attended by buyers from the entire Silicon Valley. AQUISS(TM) will be featured at two additional trade shows in October in the San Francisco and Oakland areas.

The Aquiss of Life experience of the week comes from a professional basketball player who had been plagued with muscle cramps, preventing him from playing for long periods of time. He now drinks AQUISS(TM). He attributes to AQUISS(TM) his greater stamina, lack of cramps, and prolonged playing time.

AQUISS(TM) features the Company's Instant Nano Hydration and Cell Armor technologies, providing instant, direct delivery of rehydration and cell- repair-and-protection payloads into the bloodstream beginning through the membranes of the mouth. These Instant Nano Hydration and Cell Armor technologies help provide sustained wellness necessary for life's performances and vigorous longevity. In addition, the Company's nano-encapsulation technology prevents the destruction of its active payloads in the stomach.

Phlo is a biotechnology company and a manufacturer and marketer of products (primarily liquids) containing patented and patent-pending biotechnologies. Phlo is focusing its technology generation and acquisition efforts on those technologies related to enhancing cognition and personal performance, reducing the effects of aging, and preventing or ameliorating cancer.

Certain statements made herein that are not historical constitute "forward-looking" statements within the meaning of the Private Litigation Reform Act of 1995 and may contain words such as "anticipate," "believe," "expect," "future," "may," "will," "should," "plan," "projected," "intend," and similar expressions to identify such forward-looking statements. Such statements are based on a number of assumptions and on information and estimates supplied to Phlo Corporation by sources currently available to it. Such assumptions and estimates are subject to uncertainties, contingencies, and other factors, many of which are beyond Phlo Corporation's control. Actual results may differ materially from the statements set forth above.


'/>"/>
SOURCE Phlo Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Bruker AXS parent buys affiliate company
2. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
3. Sonic Foundry reports GAAP loss as Q2 revenues rise
4. Fiserv reports $113.5 million in Q1 profit
5. Third Wave reports net loss of $18.9M for 2006
6. Musicnotes reports 45 percent growth in 2006
7. Sonic Foundry reports net loss, higher revenue
8. Sonic Foundry reports first cash-positive quarter
9. Merge Healthcare reports $10.8M net loss in Q3
10. Third Wave reports $5.2M third quarter loss
11. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... TORONTO , Feb. 23, 2017 /PRNewswire/ - The ... Institute for Cancer Research (OICR) are pleased to report ... Series A financing, with Johnson & Johnson Innovation – ... investors include venture groups HealthCap, TPG Biotechnology Partners, and ... ...
(Date:2/23/2017)... Antonio, TX (PRWEB) , ... February 23, 2017 ... ... Drug Administration (FDA) de novo clearance to begin marketing the SPEAC® System, the ... indicated for adults at home or in healthcare facilities during periods of rest. ...
(Date:2/23/2017)... Feb. 23, 2017  Capricor Therapeutics, Inc. (NASDAQ: CAPR), a ... conditions, today announced that Linda Marbán, Ph.D, president and chief ... conferences: Cowen and Company 37th Annual ... ET Boston, MA ... am PT (12:00 pm ET) Dana Point, CA ...
(Date:2/22/2017)... ... February 22, 2017 , ... Kernel ... Kendall Research Systems, LLC (KRS) clinical development program. KRS is a neurotechnology ... for research and clinical applications. The terms of the transaction were not disclosed. ...
Breaking Biology Technology:
(Date:2/16/2017)... 2017  Genos, a community for personal genetic ... received Laboratory Accreditation from the College of American ... laboratories that meet stringent requirements around quality, accuracy ... "Genos is committed to maintaining the ... honored to be receiving CAP accreditation," said ...
(Date:2/10/2017)... , Feb 10, 2017 Research ... report "Personalized Medicine - Scientific and Commercial Aspects" ... ... medicine. Diagnosis is integrated with therapy for selection of treatment ... early detection and prevention of disease in modern medicine. Biochip/microarray ...
(Date:2/8/2017)... Feb. 7, 2017 Report Highlights ... The global synthetic-biology market ... billion by 2021, growing at a compound annual growth rate ... overview of the global markets for synthetic biology. - Analyses ... 2016, and projections of compound annual growth rates (CAGRs) through ...
Breaking Biology News(10 mins):